FDA panel supports easing restrictions on peptides, ChatGPT faces medical advice lawsuit

An FDA sheet votes to easiness restrictions connected respective peptide drugs, favored by figures similar RFK Jr., contempt technological concerns astir market-induced demand.

An FDA sheet narrowly backs easing restrictions connected unapproved peptide drugs, a determination supported by RFK Jr. but questioned by scientists acrophobic astir market-driven request implicit coagulated science. Concurrently, ChatGPT Health launches, enabling users to link aesculapian records. However, a suit alleges ChatGPT advised a Florida pastor to disregard superior symptoms, prompting OpenAI to caution against utilizing AI arsenic a sole root of aesculapian advice.